RadNet Shares Outstanding 2010-2025 | RDNT

RadNet shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
RadNet Annual Shares Outstanding
(Millions of Shares)
2024 75
2023 65
2022 57
2021 53
2020 51
2019 50
2018 49
2017 47
2016 47
2015 45
2014 43
2013 40
2012 39
2011 39
2010 37
2009 36
RadNet Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 74
2024-12-31 75
2024-09-30 75
2024-06-30 73
2024-03-31 69
2023-12-31 65
2023-09-30 69
2023-06-30 61
2023-03-31 58
2022-12-31 57
2022-09-30 58
2022-06-30 57
2022-03-31 56
2021-12-31 53
2021-09-30 54
2021-06-30 53
2021-03-31 53
2020-12-31 51
2020-09-30 52
2020-06-30 51
2020-03-31 50
2019-12-31 50
2019-09-30 50
2019-06-30 50
2019-03-31 50
2018-12-31 49
2018-09-30 49
2018-06-30 49
2018-03-31 48
2017-12-31 47
2017-09-30 48
2017-06-30 47
2017-03-31 47
2016-12-31 47
2016-09-30 46
2016-06-30 47
2016-03-31 47
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 43
2014-12-31 43
2014-09-30 44
2014-06-30 43
2014-03-31 40
2013-12-31 40
2013-09-30 39
2013-06-30 40
2013-03-31 39
2012-12-31 39
2012-09-30 40
2012-06-30 39
2012-03-31 38
2011-12-31 39
2011-09-30 38
2011-06-30 40
2011-03-31 37
2010-12-31 37
2010-09-30 37
2010-06-30 37
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.247B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.115B 18.84
Encompass Health (EHC) United States $11.985B 25.41
DaVita (DVA) United States $10.433B 14.67
Chemed (CHE) United States $8.332B 26.19
Elanco Animal Health (ELAN) United States $6.288B 13.47
Option Care Health (OPCH) United States $5.143B 22.93
Amedisys (AMED) United States $3.066B 20.62
LifeStance Health (LFST) United States $2.135B 0.00
Addus HomeCare (ADUS) United States $2.064B 22.66
Astrana Health (ASTH) United States $1.362B 33.74
U.S Physical Therapy (USPH) United States $1.123B 28.98
Aveanna Healthcare Holdings (AVAH) United States $1.038B 59.11
Pennant (PNTG) United States $0.957B 35.15
Atai Life Sciences (ATAI) Germany $0.413B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00